Close
Help
Need Help?





JOURNAL

Clinical Medicine Insights: Endocrinology and Diabetes

139,999 Journal Article Views | Journal Analytics

Submit a Paper




Editor in Chief

Nigel Irwin

Dr Nigel Irwin BSc (Hons), PhD, PgCHEP, is a Lecturer in Pharmacology at the University of Ulster, Coleraine, Northern Ireland, UK. He was awarded his primary degree in Biomedical Sciences at the University of Ulster, Coleraine and subsequently completed his PhD studies in Diabetes and Endocrinology at Ulster. Dr Irwin also spent a research year in diabetes at the University of Nevada, Reno, USA.

His current research theme focuses on the potential of novel incretin-based drugs for the treatment of degenerative diseases. Dr Irwin holds several patents and has published over 120 peer-reviewed publications and presentations at national and international conferences. He is a member of several professional societies, committees and editorial boards and has received honours and awards for his work to date. Dr Irwin regularly reviews papers and grants for leading organisations.

profile details Email Address: Twitter: http://twitter.com/CMEndocrinology



Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Clinical Medicine Insights: Endocrinology and Diabetes
My experience with Libertas Academica was excellent. The review process was smooth and speedy. After publishing, I received a kind and favorable response from a reader. I have never experienced such a comment after my publications to orthodox journals.
Dr Hiro Koshiyama (Kitano Hospital, Osaka, Japan, and Kyoto University, Kyoto, Japan)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results